Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

  • There is currently no data for AGL

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Mon, 22nd Jan 2024 18:03

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Current stock price: 17.85 pence, down 8.5% in London on Monday

12-month change: down 42%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related News

IN BRIEF: Angle names Peter Collins as interim CEO
16 Oct 2025

IN BRIEF: Angle names Peter Collins as interim CEO

(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...

Angle touts planned name and strategy change, Groen turns executive
8 Oct 2025

Angle touts planned name and strategy change, Groen turns executive

(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...

IN BRIEF: Angle CEO and finance lead step down after shareholder talks
12 Sep 2025

IN BRIEF: Angle CEO and finance lead step down after shareholder talks

Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...

Angle News

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan
25 Oct 2023

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Angle hails study which shows Parsortix outperforming lab standard
3 Oct 2023

Angle hails study which shows Parsortix outperforming lab standard

(Alliance News) - Angle PLC on Tuesday touted the publication of a study by researchers at the University of Tubingen in Germany, which showed that it...

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival
14 Sep 2023

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges
7 Sep 2023

EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends
7 Sep 2023

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Angle launches tumour cell assay to "unlock" customised cancer care
4 Sep 2023

Angle launches tumour cell assay to "unlock" customised cancer care

(Alliance News) - Angle PLC on Monday announced the launch of its new Portrait Flex circulating tumour cell assay, which it said will provide valuable...

IN BRIEF: Angle hires Swansiger as new COO and Miller as new CSO
5 Jun 2023

IN BRIEF: Angle hires Swansiger as new COO and Miller as new CSO

Angle PLC - Guildford, England-based liquid biopsy company - Hires Brett Swansiger as chief commercial officer and Karen Miller as chief scientific of...